Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 272 results for "ranbaxy industries"

Sun Pharmaceutical Industries and Ranbaxy (UK) v Commission (J...

 [ New search ] [ Help ] JUDGMENT OF THE GENERAL COURT (Ninth Chamber) 8 September 2016 ( * ) (Competition— Agreements, decisions and concerted practices— Market for antidepressant medicinal products containing the active ..., 2 weeks ago

4 images for ranbaxy industries, 1 month ago
The Freepress Journal, 2 months ago
Money Today, 6 months ago
Money Control, 7 months ago

Mukesh Ambani richest Indian 9th year in a row

Industrialist Mukesh Ambani was today named India's richest person for a ninth year in a row with a sharp increase in networth to USD 22.7 billion, while Sun Pharma's Dilip Shanghvi was ranked a distant second with a wealth of USD 16.9 billion. ...
 Smart Investor4 days ago Mukesh Ambani India's richest for 9th yr, Shanghvi at 2nd spot  Daily Excelsior.com4 days ago With $22.7 billion in his kitty, Mukesh Ambani is India's richest  Rediff.com5 days ago

Ranbaxy dragged into GOP's fight with Hillary Clinton

MUMBAI: A Republican Congresswoman and bitter foe of US presidential candidate Hillary Clinton has dragged Ranbaxy Labs into her latest attack on the Democratic nominee. Congresswoman Marsha Blackburn's letter, a 71-page report embossed with the ...
 Economic Times5 days ago

FDA norms punch a Rs 5 crore hole in Pharma Industry

ET INTELLIGENCE GROUP: For Indian pharmaceutical companies, compliance with US Food and Drug Administration norms has emerged as the most critical risk in the past few years. The most dramatic reflection of this is in the way legal and professional ...
 Economic Times1 week ago FDA norms punch a Rs 5,000 crore hole in Pharma Industry  Pharmaceutical Tech.com1 week ago

Spike in pharma companies challenging regulator on price order

Tension between pharmaceutical companies and the price regulator for the sector is on the rise. While the industry has taken some of their disputes with the National Pharmaceutical Pricing Authority (NPPA) to court, many others have landed up time ...
 Smart Investor2 weeks ago Making Ranbaxy units cGMP compliant time consuming: Sun Pharma  Livemint.com1 month ago Grim diagnosis for pharma firms haunted by price bogey  Smart Investor1 week ago Pharmalot, Pharmalittle: India wants you to know its drugs are safe and effective  StatNews.com1 month ago

Sun Pharma Q1 net zooms over 3-fold at Rs 2,034 cr on strong US sales

A man carrying a gas cylinder walks out of the research and development centre of Sun Pharmaceutical Industries in Mumbai. Photo: Reuters Sun Pharmaceutical Industries posted 3.6 per cent times growth in consolidated net profit in Q1FY17 on a ...
 Business Standard India1 month ago Sun Pharma Q1 net jumps over three times  The Hindu1 month ago Sun Pharma Q1 net jumps 3-fold; US, India sales grow  Times of India1 month ago

Equal Weight Sun Pharmaceutical Industries Ltd., target Rs 846.0 : Morgan Stanley

Morgan Stanley has Equal Weight call on Sun Pharmaceutical Industries Ltd. with a target price of Rs 846.0. The current market price of Sun Pharmaceutical Industries Ltd. is 797.0. Time period given by analyst is year, when Sun Pharmaceutical ...
 Economic Times1 month ago Buy Sun Pharmaceutical Industries Ltd., target Rs 925.0 : Motilal Oswal Securities  Economic Times1 month ago

Buzzing stocks: Oberoi Realty jumps, Welspun India tumbles, Minda Industries up

Welspun India Ltd hit 20% lower circuit on the BSE. Welspun India Ltd has announced in reference to a product specification issue with one client program of its subsidiary WGBL. Infosys Ltd is currently trading at Rs. 1012.15, down by Rs. 8.95 or ...
 India Infoline1 month ago Welspun fiasco shows Indian companies have a blind spot on quality  Livemint.com4 weeks ago India market is very important to us  Express Pharma2 months ago

Ranbaxy-Daiichi affair: How & why the deal went south

The Singapore International Arbitration Centre's (SIAC's) order in the Ranbaxy-Daiichi case has revealed in detail how the Indian pharmaceutical major withheld pertinent information from Japan's Daiichi-Sankyo, reported The Indian Express on ...
 Smart Investor1 month ago

Mumbai court directs Sun Pharma to pay pending wages to 86 employees

Mumbai court holds Sun Pharma responsible for committing unfair labour practices after its merger with Ranbaxy Laboratories in March 2015 Mumbai: India's largest drug maker Sun Pharmaceutical Industries Ltd has suffered a setback in its tussle with ...
 Livemint.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less